Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current Challenges
Promising emerging technologies have considerable potential to expand TDM to cover a wide range of drugs, making precision medicine accessible to many patients.
Authors
- Lin Du (ORCID: https://orcid.org/0009-0005-2589-7082)
- Laurent Arthur Decosterd (ORCID: https://orcid.org/0000-0002-9840-1325)
- Nicolas Widmer (ORCID: https://orcid.org/0000-0001-7392-2418)
- Monia Guidi (ORCID: https://orcid.org/0000-0002-6419-9317)
- Catia Marzolini (ORCID: https://orcid.org/0000-0002-2312-7050)
- Myriam Briki (ORCID: https://orcid.org/0000-0001-6334-5565)
- Yann Thoma (ORCID: https://orcid.org/0000-0003-4374-6104)
- Thierry Buclin (ORCID: https://orcid.org/0000-0003-0639-5536)
- Francesca Rodino (ORCID: https://orcid.org/0000-0003-4227-0183)
- Sandro Carrara (ORCID: https://orcid.org/0000-0003-0404-7917)
Institutions
- University of Geneva (CH)
- University of Liverpool (GB)
- HES-SO University of Applied Sciences and Arts Western Switzerland (CH)
- University Hospital of Basel (CH)
- Pharmacy of the Eastern Vaud Hospitals (CH)
- HES-SO Vaud (CH)
- École Polytechnique Fédérale de Lausanne (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1097/ftd.0000000000001384
- Citations
- 2
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung